SIMPLEX TRADING, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 144 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$4
-60.0%
188
-24.8%
0.00%
Q1 2023$10
-9.1%
2500.0%0.00%
Q4 2022$11
-100.0%
250
-89.7%
0.00%
Q4 2021$181,000
+5933.3%
2,428
+3368.6%
0.00%
Q2 2020$3,000
-86.4%
70
-84.1%
0.00%
Q1 2020$22,000
-58.5%
441
-50.6%
0.00%
Q3 2019$53,000
+140.9%
893
+182.6%
0.00%
Q4 2018$22,000
-95.7%
316
-92.8%
0.00%
-100.0%
Q2 2018$508,000
+53.5%
4,390
-22.2%
0.00%
-85.7%
Q4 2017$331,000
+86.0%
5,644
+14.0%
0.01%
+75.0%
Q2 2017$178,000
+3460.0%
4,953
+2779.7%
0.01%
Q1 2016$5,000
-98.4%
172
-98.2%
0.00%
-100.0%
Q4 2015$312,000
+1542.1%
9,472
+1622.2%
0.02%
+2300.0%
Q3 2015$19,000
-26.9%
550
-4.8%
0.00%
-50.0%
Q2 2015$26,000
-7.1%
578
-38.7%
0.00%
-33.3%
Q1 2015$28,000
-67.1%
943
-43.8%
0.00%
-70.0%
Q4 2014$85,0001,6790.01%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 511,186$43,686,00011.23%
GREAT POINT PARTNERS LLC 210,400$17,981,0002.80%
ARMISTICE CAPITAL, LLC 456,000$38,970,0002.34%
Matarin Capital Management, LLC 210,208$17,964,376,0001.16%
Sapphire Star Partners LP 8,168$698,0000.70%
Granahan Investment Management 103,320$8,830,0000.48%
FARALLON CAPITAL MANAGEMENT LLC 867,500$74,137,0000.44%
361 CAPITAL LLC 19,040$1,627,0000.35%
ALGERT GLOBAL LLC 17,922$1,532,0000.33%
AlphaMark Advisors, LLC 9,310$796,0000.32%
View complete list of ENANTA PHARMACEUTICALS INC shareholders